Company: CRAC
Filing Date: 2025-07-11
Form Type: S-1/A
Source: 0001213900-25-063347
Chunk: 209

Company: Crown Reserve Acquisition Corp. I
Filing Date: 2025-07-11
Form: S-1/A
Chunk 209
---
 payment of $5,882,859. •Aesther Healthcare Acquisition Corp. (n/k/a Ocean Biomedical, Inc. (NASDAQ: OCEA)) — Mr.Patel served as a board advisor. Mr.Peterson has served as a director from June 2021 until the completion of its initial business combination in February 2023. Mr. Peterson now serves as a director of the post -combinationcompany. Mr. Fell served as a director from June 2021 until the completion of its initial business combination in February 2023. On February14, 2023, Aesther Healthcare Acquisition Corp. (“AHAC”) completed the acquisition of Ocean Biomedical Holdings, Inc. pursuant to a definitive agreement, as amended. AHAC exercised two three -monthextension options to complete the transaction. Upon closing the agreement, AHAC changed its name from “Aesther Healthcare Acquisition Corp.” to “Ocean Biomedical, Inc.” Prior to the closing of the business combination, certain AHAC public shareholders exercised their right to redeem certain of their outstanding shares for cash, resulting in the redemption of 10,389,093shares of the company’s Class A common stock for an aggregate payment of $58,847,564.50. •Kernel Group Holdings, Inc. (NASDAQ: KRNL) — Mr. Peterson has served as a director since December 2022. Mr. Fell has served as a director since December 2022. On August5, 2024, Kernel Group Holdings, Inc. issued a press release announcing it will redeem all of its outstanding Class A ordinary shares, par value $0.0001, effective as of the close of business on August5, 2024, because the company would not consummate an initial business combination within the time period required by its Amended and Restated Memorandum and Articles of Association. •Integrated Wellness Acquisition Corp (OTC: WELNF) — Mr. Peterson has served as director since February 2024. Mr. Fell has served as director since February 2024. The company extended the period of time it had to consummate its initial business combination by an aggregate of 33 months; however, the company has not consummated its initial business combination. •Semper Paratus Acquisition Corporation (n/k/a Tevogen Bio Holdings Inc. (NASDAQ: TVGN)) — Mr. Peterson served as director from June 2023 until the completion of its initial business combination in February 2024. Mr. Fell served